EHC

Encompass Health Corp

EHC.US encompasshealth.com
122.81
+1.10 (+0.90%)
USD · NYSE
52-week range
92.41
127.50
Trading at 87% of the 52-week range
Market Cap
12.01B
P/E Ratio
20.32
Forward P/E
18.83
Book Value
26.29
Div. Yield
0.63%
% Institutions
100.11%
% Insiders
0.867%

1 Year

-3.3%

3 Year

+82.1%

10 Year

+334.4%
Description

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Company Information

Company Name
Encompass Health Corp
Sector
Healthcare
Industry
Medical Care Facilities
Exchange
NYSE
ISIN: US29261A1007
CIK: 0000785161
CUSIP: 394797AB0
Currency: USD
Full Time Employees: 29,699
Phone: 205 967 7116
Fiscal Year End: December
IPO Date: Sep 30, 1986
Description:

Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.

Address:

9001 Liberty Parkway, Birmingham, AL, United States, 35242

People

Directors & Officers

Name Title Year Born
Mr. Mark J. Tarr CEO, President & Director 1962
Mr. Douglas E. Coltharp Executive VP & CFO 1962
Mr. Patrick W. Tuer Executive VP & COO 1985
Mr. John Patrick Darby Executive VP, General Counsel & Corporate Secretary 1965
Dr. Elissa Joy Charbonneau D.O., M.S. Chief Medical Officer 1960
Mr. Andrew L. Price Senior VP & Chief Accounting Officer 1967
Mr. Rusty Yeager Chief Information Officer & Senior VP NA
Mr. Mark Miller Senior Vice President of Investor Relations & Strategic Planning NA
Ms. Dawn Rock Chief Compliance Officer NA
Mr. Anthony A. Hernandez Chief Human Resources Officer 1966

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Mar 09, 2026 Edmund Fay N/A Sale 11.94K $107.00 $1.28M
Feb 11, 2026 Mark J Tarr N/A Sale 150.00K $111.64 $16.75M
Oct 31, 2025 Lisa C. McClain N/A Sale N/A $113.86 N/A
Oct 30, 2025 Lisa C. McClain N/A Sale N/A $118.04 N/A
Oct 30, 2025 Lisa C. McClain N/A Purchase N/A $118.04 N/A
Aug 27, 2025 Patrick William Tuer N/A Sale 1.02K $123.59 $126.06K
Jul 22, 2025 Lisa C. McClain N/A Purchase N/A $108.43 N/A
May 20, 2025 Mark J Tarr N/A Sale 118.38K $121.53 $14.39M
May 06, 2025 Elissa Joy Charbonneau N/A Sale 4.28K $116.61 $498.97K
Apr 29, 2025 John Patrick Darby N/A Sale 10.00K $114.79 $1.15M

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 10.77M Mar 31, 2026 10.92% $0.02 4.46%
Vanguard Portfolio Management, LLC 4.96M Mar 31, 2026 5.03% $0.03 0.00%
T. Rowe Price Associates, Inc. 4.60M Mar 31, 2026 4.66% $0.05 -4.26%
Vanguard Capital Management, LLC 4.47M Mar 31, 2026 4.53% $0.01 0.00%
Amvescap Plc. 3.39M Mar 31, 2026 3.43% $0.03 -31.91%
Wellington Management Company LLP 3.28M Jun 30, 2026 3.32% $0.06 -14.81%
T. Rowe Price Investment Management,Inc. 3.23M Mar 31, 2026 3.27% $0.22 -28.83%
State Street Corp 3.14M Mar 31, 2026 3.19% $0.01 1.85%
AllianceBernstein L.P. 2.62M Mar 31, 2026 2.66% $0.09 40.42%
Citadel Advisors Llc 2.56M Jun 30, 2026 2.60% $0.03 400.72%
Two Sigma Investments LLC 2.27M Jun 30, 2026 2.30% $0.17 2.05%
Fuller & Thaler Asset Management Inc 2.23M Mar 31, 2026 2.26% $0.73 -45.71%
Geode Capital Management, LLC 1.90M Mar 31, 2026 1.92% $0.01 -2.44%
The Goldman Sachs Group Inc 1.81M Mar 31, 2026 1.83% $0.02 299.67%
Dimensional Fund Advisors, Inc. 1.74M Jun 30, 2026 1.77% $0.03 4.07%
JPMorgan Chase & Co 1.23M Mar 31, 2026 1.25% $0.01 12.05%
Arrowstreet Capital Limited Partnership 1.18M Mar 31, 2026 1.20% $0.06 1.61%
NORGES BANK 1.15M Jun 30, 2026 1.17% $0.01 -7.99%
William Blair Investment Management, LLC 1.15M Jun 30, 2026 1.17% $0.35 43.32%
American Century Companies Inc 1.05M Jun 30, 2026 1.06% $0.05 39.68%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Mid-Cap ETF 3.47M 3.52% ▲ 0.04% Aug 31, 2026
2 Vanguard MStar Total Stk Mkt Idx Invest 3.16M 3.20% ▲ 0.29% Jul 31, 2026
3 FullerThaler Behavioral Sm-Cp Eq R6 2.35M 2.38% ▲ 10.51% Jun 30, 2026
4 FullerThaler Beh Small-Cap Equity SMA 2.35M 2.38% ▲ 19.85% Jun 30, 2026
5 FullerThaler Behavioral Small-Cap Equity 2.35M 2.38% ▲ 10.51% Jun 30, 2026
6 Vanguard Small Cap Index 2.28M 2.31% ▲ 0.21% Jul 31, 2026
7 Vanguard MStar Small Cap Value Index 1.45M 1.47% ▲ 0.28% Jul 31, 2026
8 Vanguard Health Care Inv 1.42M 1.44% ▼ 11.12% Jun 30, 2026
9 T. Rowe Price US Large-Cap Core Tr-E 1.27M 1.29% ▲ 11.79% Jun 30, 2026
10 T. Rowe Price US Large-Cap Core Eq Comp 1.16M 1.18% ▲ 7.80% Jun 30, 2026

Financial Highlights

Market Cap: $12.01B
EBITDA: $1.46B
P/E Ratio: $20.32
PEG Ratio: $0.41
Book Value: $26.29
Dividend/Share: $0.76
Dividend Yield: 0.63%
Earnings/Share: $5.99
Profit Margin: 10.01%
Operating Margin: 18.05%
ROA (TTM): 9.80%
ROE (TTM): 24.97%
Revenue (TTM): $6.21B
Revenue/Share (TTM): $62.25
Earnings Growth (YOY): 10.80%
Revenue Growth (YOY): 9.60%

Valuation Metrics

Enterprise Value: $14.74B
Trailing P/E: 20.32
Forward P/E: 18.83

Shares Statistics

Shares Outstanding: 98.65M
Shares Float: 97.65M
% Insiders: 0.867%
% Institutions: 100.11%
Short % Float: 3.70%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$5.94B
Cost of Goods Sold
adjust
$-254.40M
Gross Profit
subtotal
$5.68B
SG&A
adjust
$-3.41B
Other Operating Expense
adjust
$-1.22B
Operating Income
subtotal
$1.05B
Other / Non-Operating Items
adjust
$-486.90M
Net Income
subtotal
$566.20M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about EHC.US!